IVD Contract Manufacturing Market (By Device Type: IVD Equipment, IVD Consumables; By Technology: Immunoassay, Clinical Chemistry, Molecular Diagnostics, Microbiology, Hematology, Coagulation & Hemostasis, Others; By Service Type: Manufacturing Services, Assay Development Services, Other Services) - Global Industry Analysis, Size, Share, Growth, Trends, Regional Outlook, and Forecast 2023-2032

Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology (Premium Insights)

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope 

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis 

4.3.2. Sales and Distribution Channel Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. COVID 19 Impact on IVD Contract Manufacturing Market 

5.1. COVID-19 Landscape: IVD Contract Manufacturing Industry Impact

5.2. COVID 19 - Impact Assessment for the Industry

5.3. COVID 19 Impact: Global Major Government Policy

5.4. Market Trends and Opportunities in the COVID-19 Landscape

Chapter 6. Market Dynamics Analysis and Trends

6.1. Market Dynamics

6.1.1. Market Drivers

6.1.2. Market Restraints

6.1.3. Market Opportunities

6.2. Porter’s Five Forces Analysis

6.2.1. Bargaining power of suppliers

6.2.2. Bargaining power of buyers

6.2.3. Threat of substitute

6.2.4. Threat of new entrants

6.2.5. Degree of competition

Chapter 7. Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis

7.1.2. Key Strategies Adopted by Players

7.1.3. Vendor Landscape

7.1.3.1. List of Suppliers

7.1.3.2. List of Buyers

Chapter 8. Global IVD Contract Manufacturing Market, By Device Type

8.1. IVD Contract Manufacturing Market, by Device Type, 2023-2032

8.1.1 IVD Equipment

8.1.1.1. Market Revenue and Forecast (2020-2032)

8.1.2. IVD Consumables

8.1.2.1. Market Revenue and Forecast (2020-2032)

Chapter 9. Global IVD Contract Manufacturing Market, By Technology

9.1. IVD Contract Manufacturing Market, by Technology, 2023-2032

9.1.1. Immunoassay

9.1.1.1. Market Revenue and Forecast (2020-2032)

9.1.2. Clinical Chemistry

9.1.2.1. Market Revenue and Forecast (2020-2032)

9.1.3. Molecular Diagnostics

9.1.3.1. Market Revenue and Forecast (2020-2032)

9.1.4. Microbiology

9.1.4.1. Market Revenue and Forecast (2020-2032)

9.1.5. Hematology

9.1.5.1. Market Revenue and Forecast (2020-2032)

9.1.6. Coagulation & Hemostasis

9.1.6.1. Market Revenue and Forecast (2020-2032)

9.1.7. Others

9.1.7.1. Market Revenue and Forecast (2020-2032)

Chapter 10. Global IVD Contract Manufacturing Market, By Service Type 

10.1. IVD Contract Manufacturing Market, by Service Type, 2023-2032

10.1.1. Manufacturing Services

10.1.1.1. Market Revenue and Forecast (2020-2032)

10.1.2. Assay Development Services

10.1.2.1. Market Revenue and Forecast (2020-2032)

10.1.3. Other Services

10.1.3.1. Market Revenue and Forecast (2020-2032)

Chapter 11. Global IVD Contract Manufacturing Market, Regional Estimates and Trend Forecast

11.1. North America

11.1.1. Market Revenue and Forecast, by Device Type (2020-2032)

11.1.2. Market Revenue and Forecast, by Technology (2020-2032)

11.1.3. Market Revenue and Forecast, by Service Type (2020-2032)

11.1.4. U.S.

11.1.4.1. Market Revenue and Forecast, by Device Type (2020-2032)

11.1.4.2. Market Revenue and Forecast, by Technology (2020-2032)

11.1.4.3. Market Revenue and Forecast, by Service Type (2020-2032)

11.1.5. Rest of North America

11.1.5.1. Market Revenue and Forecast, by Device Type (2020-2032)

11.1.5.2. Market Revenue and Forecast, by Technology (2020-2032)

11.1.5.3. Market Revenue and Forecast, by Service Type (2020-2032)

11.2. Europe

11.2.1. Market Revenue and Forecast, by Device Type (2020-2032)

11.2.2. Market Revenue and Forecast, by Technology (2020-2032)

11.2.3. Market Revenue and Forecast, by Service Type (2020-2032)

11.2.4. UK

11.2.4.1. Market Revenue and Forecast, by Device Type (2020-2032)

11.2.4.2. Market Revenue and Forecast, by Technology (2020-2032)

11.2.4.3. Market Revenue and Forecast, by Service Type (2020-2032)

11.2.5. Germany

11.2.5.1. Market Revenue and Forecast, by Device Type (2020-2032)

11.2.5.2. Market Revenue and Forecast, by Technology (2020-2032)

11.2.5.3. Market Revenue and Forecast, by Service Type (2020-2032)

11.2.6. France

11.2.6.1. Market Revenue and Forecast, by Device Type (2020-2032)

11.2.6.2. Market Revenue and Forecast, by Technology (2020-2032)

11.2.6.3. Market Revenue and Forecast, by Service Type (2020-2032)

11.2.7. Rest of Europe

11.2.7.1. Market Revenue and Forecast, by Device Type (2020-2032)

11.2.7.2. Market Revenue and Forecast, by Technology (2020-2032)

11.2.7.3. Market Revenue and Forecast, by Service Type (2020-2032)

11.3. APAC

11.3.1. Market Revenue and Forecast, by Device Type (2020-2032)

11.3.2. Market Revenue and Forecast, by Technology (2020-2032)

11.3.3. Market Revenue and Forecast, by Service Type (2020-2032)

11.3.4. India

11.3.4.1. Market Revenue and Forecast, by Device Type (2020-2032)

11.3.4.2. Market Revenue and Forecast, by Technology (2020-2032)

11.3.4.3. Market Revenue and Forecast, by Service Type (2020-2032)

11.3.5. China

11.3.5.1. Market Revenue and Forecast, by Device Type (2020-2032)

11.3.5.2. Market Revenue and Forecast, by Technology (2020-2032)

11.3.5.3. Market Revenue and Forecast, by Service Type (2020-2032)

11.3.6. Japan

11.3.6.1. Market Revenue and Forecast, by Device Type (2020-2032)

11.3.6.2. Market Revenue and Forecast, by Technology (2020-2032)

11.3.6.3. Market Revenue and Forecast, by Service Type (2020-2032)

11.3.7. Rest of APAC

11.3.7.1. Market Revenue and Forecast, by Device Type (2020-2032)

11.3.7.2. Market Revenue and Forecast, by Technology (2020-2032)

11.3.7.3. Market Revenue and Forecast, by Service Type (2020-2032)

11.4. MEA

11.4.1. Market Revenue and Forecast, by Device Type (2020-2032)

11.4.2. Market Revenue and Forecast, by Technology (2020-2032)

11.4.3. Market Revenue and Forecast, by Service Type (2020-2032)

11.4.4. GCC

11.4.4.1. Market Revenue and Forecast, by Device Type (2020-2032)

11.4.4.2. Market Revenue and Forecast, by Technology (2020-2032)

11.4.4.3. Market Revenue and Forecast, by Service Type (2020-2032)

11.4.5. North Africa

11.4.5.1. Market Revenue and Forecast, by Device Type (2020-2032)

11.4.5.2. Market Revenue and Forecast, by Technology (2020-2032)

11.4.5.3. Market Revenue and Forecast, by Service Type (2020-2032)

11.4.6. South Africa

11.4.6.1. Market Revenue and Forecast, by Device Type (2020-2032)

11.4.6.2. Market Revenue and Forecast, by Technology (2020-2032)

11.4.6.3. Market Revenue and Forecast, by Service Type (2020-2032)

11.4.7. Rest of MEA

11.4.7.1. Market Revenue and Forecast, by Device Type (2020-2032)

11.4.7.2. Market Revenue and Forecast, by Technology (2020-2032)

11.4.7.3. Market Revenue and Forecast, by Service Type (2020-2032)

11.5. Latin America

11.5.1. Market Revenue and Forecast, by Device Type (2020-2032)

11.5.2. Market Revenue and Forecast, by Technology (2020-2032)

11.5.3. Market Revenue and Forecast, by Service Type (2020-2032)

11.5.4. Brazil

11.5.4.1. Market Revenue and Forecast, by Device Type (2020-2032)

11.5.4.2. Market Revenue and Forecast, by Technology (2020-2032)

11.5.4.3. Market Revenue and Forecast, by Service Type (2020-2032)

11.5.5. Rest of LATAM

11.5.5.1. Market Revenue and Forecast, by Device Type (2020-2032)

11.5.5.2. Market Revenue and Forecast, by Technology (2020-2032)

11.5.5.3. Market Revenue and Forecast, by Service Type (2020-2032)

Chapter 12. Company Profiles

12.1. Thermo Fisher Scientific Inc.

12.1.1. Company Overview

12.1.2. Product Offerings

12.1.3. Financial Performance

12.1.4. Recent Initiatives

12.2. Siemens Healthineers AG

12.2.1. Company Overview

12.2.2. Product Offerings

12.2.3. Financial Performance

12.2.4. Recent Initiatives

12.3. Danaher Corporation

12.3.1. Company Overview

12.3.2. Product Offerings

12.3.3. Financial Performance

12.3.4. Recent Initiatives

12.4. Roche Diagnostics

12.4.1. Company Overview

12.4.2. Product Offerings

12.4.3. Financial Performance

12.4.4. Recent Initiatives

12.5. Ortho Clinical Diagnostics

12.5.1. Company Overview

12.5.2. Product Offerings

12.5.3. Financial Performance

12.5.4. Recent Initiatives

12.6. Abbott Laboratories

12.6.1. Company Overview

12.6.2. Product Offerings

12.6.3. Financial Performance

12.6.4. Recent Initiatives

12.7. Bio-Rad Laboratories, Inc.

12.7.1. Company Overview

12.7.2. Product Offerings

12.7.3. Financial Performance

12.7.4. Recent Initiatives

12.8. Sysmex Corporation

12.8.1. Company Overview

12.8.2. Product Offerings

12.8.3. Financial Performance

12.8.4. Recent Initiatives

12.9. Quidel Corporation

12.9.1. Company Overview

12.9.2. Product Offerings

12.9.3. Financial Performance

12.9.4. Recent Initiatives

12.10. BioMérieux SA

12.10.1. Company Overview

12.10.2. Product Offerings

12.10.3. Financial Performance

12.10.4. Recent Initiatives

Chapter 13. Research Methodology

13.1. Primary Research

13.2. Secondary Research

13.3. Assumptions

Chapter 14. Appendix

14.1. About Us

14.2. Glossary of Terms

PROCEED TO BUY :

   USD 4900
   USD 3800
   USD 2100
   USD 2100
   USD 7500

ASK FOR SAMPLE

No cookie-cutter, only authentic analysis – take the 1st step to become an Precedence Research client

Get a Sample